Quidel Total Assets 2006-2019 | QDEL

Quidel total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Quidel Annual Total Assets
(Millions of US $)
2018 $806
2017 $935
2016 $388
2015 $407
2014 $447
2013 $271
2012 $242
2011 $279
2010 $215
2009 $166
2008 $143
2007 $134
2006 $127
2005 $114
Quidel Quarterly Total Assets
(Millions of US $)
Q2 2019 $846
Q1 2019 $906
Q4 2018 $806
Q3 2018 $794
Q2 2018 $764
Q1 2018 $866
Q4 2017 $935
Q3 2017 $414
Q2 2017 $399
Q1 2017 $404
Q4 2016 $388
Q3 2016 $376
Q2 2016 $370
Q1 2016 $379
Q4 2015 $407
Q3 2015 $419
Q2 2015 $429
Q1 2015 $455
Q4 2014 $447
Q3 2014 $268
Q2 2014 $259
Q1 2014 $271
Q4 2013 $271
Q3 2013 $266
Q2 2013 $265
Q1 2013 $257
Q4 2012 $242
Q3 2012 $237
Q2 2012 $233
Q1 2012 $238
Q4 2011 $279
Q3 2011 $273
Q2 2011 $254
Q1 2011 $263
Q4 2010 $215
Q3 2010 $213
Q2 2010 $221
Q1 2010 $233
Q4 2009 $166
Q3 2009 $150
Q2 2009 $119
Q1 2009 $125
Q4 2008 $143
Q3 2008 $149
Q2 2008 $133
Q1 2008 $134
Q4 2007 $134
Q3 2007 $120
Q2 2007 $114
Q1 2007 $118
Q4 2006 $127
Q3 2006 $108
Q2 2006 $108
Q1 2006 $116
Q4 2005 $114
Q3 2005 $98
Q2 2005 $90
Q1 2005 $110
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.645B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.825B 27.79
Medtronic (MDT) Ireland $147.584B 20.72
Stryker (SYK) United States $82.482B 28.52
Boston Scientific (BSX) United States $59.759B 28.99
Baxter (BAX) United States $44.643B 27.07
EssilorLuxottica Societe Anonyme (ESLOY) France $31.425B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.623B 18.32
Coloplast (CLPBY) Denmark $25.682B 41.00
Lonza Group Ag (LZAGY) Switzerland $25.628B 0.00
Terumo (TRUMY) Japan $22.710B 26.11
Smith & Nephew SNATS (SNN) United Kingdom $20.792B 0.00
ResMed (RMD) United States $19.048B 36.32
Sunny Optical Technology (SNPTF) China $16.288B 0.00
Bio-Rad Laboratories (BIO) United States $10.082B 54.05
Canopy Growth (CGC) Canada $10.015B 0.00
Insulet (PODD) United States $8.923B 528.71
Perrigo (PRGO) Ireland $7.527B 13.86
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.973B 20.79
Haemonetics (HAE) United States $6.488B 48.96
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.377B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.192B 0.00
Neogen (NEOG) United States $4.086B 67.83
NuVasive (NUVA) United States $3.383B 26.97
ICU Medical (ICUI) United States $3.322B 21.55
Hutchison China MediTech (HCM) China $2.766B 0.00
Agios Pharmaceuticals (AGIO) United States $2.144B 0.00
National Vision Holdings (EYE) United States $2.086B 45.03
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.577B 0.00
VAREX IMAGING (VREX) United States $1.099B 25.32
AtriCure (ATRC) United States $1.000B 0.00
Lantheus Holdings (LNTH) United States $0.999B 26.25
Omeros (OMER) United States $0.912B 0.00
Phibro Animal Health (PAHC) United States $0.882B 14.34
NanoString Technologies (NSTG) United States $0.807B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.793B 20.22
Cerus (CERS) United States $0.744B 0.00
PetIQ (PETQ) United States $0.740B 17.47
LeMaitre Vascular (LMAT) United States $0.710B 42.09
MacroGenics (MGNX) United States $0.631B 0.00
Surmodics (SRDX) United States $0.623B 118.46
TG Therapeutics (TGTX) United States $0.609B 0.00
Quanterix (QTRX) United States $0.598B 0.00
OraSure Technologies (OSUR) United States $0.463B 21.43
Meridian Bioscience (VIVO) United States $0.413B 12.88
BioLife Solutions (BLFS) United States $0.399B 131.13
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.373B 0.00
Utah Medical Products (UTMD) United States $0.371B 27.17
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.304B 32.28
United Health Products (UEEC) United States $0.293B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Rockwell Medical (RMTI) United States $0.213B 0.00
Cytosorbents (CTSO) United States $0.174B 0.00
Vapotherm (VAPO) United States $0.171B 0.00
Chimerix (CMRX) United States $0.146B 0.00
Fonar (FONR) United States $0.143B 10.19
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
InfuSystems Holdings (INFU) United States $0.102B 0.00
United-Guardian (UG) United States $0.088B 20.88
MRI Interventions (MRIC) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00